EUVIMEDEUVIMED entdecken
Open Access

Deciphering the Molecular Basis: Integrative Multi‐Method Analysis of Bioactive Constituents and Their Anti‐Lung Cancer Mechanisms in Clinical Traditional Chinese Medicine Formulations

Bin Yu iD, Jiankun Zhang, Lin Ren, Kexin Xu iD, Huan Su, Yuemeng Zou, Hui Xu iD, Guangyao Lv iD, Jiangping Yu iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Bin Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Nuclear Technology Medical Transformation (Mianyang Central Hospital), School of Medicine, University of Electronic Science and…. Hauptthemen laut MEDLINE: Lung Neoplasms, Antineoplastic Agents, Phytogenic, Drugs, Chinese Herbal. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHC Key Laboratory of Nuclear Technology Medical Transformation (Mianyang Central Hospital), Mianyang Key Laboratory of Anesthesia and Neuroregulation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite variations in the composition of traditional Chinese medicine (TCM) formulas for lung cancer used in clinical practice, they show consistent clinical efficacy. This study employed an integrated approach combining network pharmacology, bioinformatics, and in vitro experiments to analyze 45 clinical prescriptions. From the 188 herbs identified, licorice and atractylodes rhizome were the most frequently used. Analysis revealed seven key active compounds, including quercetin and stigmasterol, acting on 149 shared targets, with significant enrichment in pathways such as PI3K/AKT. Molecular docking confirmed strong binding between core compounds and targets like PRKACA. Bioinformatics analysis of TCGA data further reveals that MMP9 may promote tumor invasion and metastasis by degrading the extracellular matrix. In vitro, quercetin and stigmasterol inhibited A549 cell proliferation and induced apoptosis, with quercetin suppressing PI3K/AKT activation. The findings indicate that licorice and atractylodes rhizome may play a synergistic role, and quercetin acts as a key anti‐cancer compound by inhibiting the PI3K/AKT pathway, elucidating a common pharmacological basis for these TCM formulas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAntineoplastic Agents, PhytogenicDrugs, Chinese HerbalHumansMolecular Docking SimulationCell ProliferationMedicine, Chinese TraditionalApoptosisProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDrug Screening Assays, AntitumorGlycyrrhizaNetwork PharmacologyA549 CellsMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

PI3K/AKT pathwaybioinformaticsclinical datalung cancermolecular dockingnetwork pharmacology

Substanzen

Antineoplastic Agents, PhytogenicProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDrugs, Chinese Herbal

Autor:innen und Institutionen

  • NHC Key Laboratory of Nuclear Technology Medical Transformation (Mianyang Central Hospital), School of Medicine, University of Electronic Science and Technology of China, Mianyang Central Hospital, Mianyang, China.
  • Department of Pediatrics, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
  • School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai, China.
  • Department of Pharmacy, Shandong Medical and Pharmaceutical University Hospital, Binzhou, China.

ORCID-Profile: Bin Yu, Kexin Xu, Hui Xu, Guangyao Lv, Jiangping Yu

Förderung

  • NHC Key Laboratory of Nuclear Technology Medical Transformation (Mianyang Central Hospital)
  • Mianyang Key Laboratory of Anesthesia and Neuroregulation

Zitieren

APA

Yu, B., Zhang, J., Ren, L., Xu, K., Su, H., Zou, Y., Xu, H., Lv, G., & Yu, J. (2026). Deciphering the Molecular Basis: Integrative Multi‐Method Analysis of Bioactive Constituents and Their Anti‐Lung Cancer Mechanisms in Clinical Traditional Chinese Medicine Formulations. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71606

Vancouver

Yu B, Zhang J, Ren L, Xu K, Su H, Zou Y, et al. Deciphering the Molecular Basis: Integrative Multi‐Method Analysis of Bioactive Constituents and Their Anti‐Lung Cancer Mechanisms in Clinical Traditional Chinese Medicine Formulations. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71606

BibTeX
@article{Yu2026,
  author = {Yu, Bin and Zhang, Jiankun and Ren, Lin and Xu, Kexin and Su, Huan and Zou, Yuemeng and Xu, Hui and Lv, Guangyao and Yu, Jiangping},
  title = {Deciphering the Molecular Basis: Integrative Multi‐Method Analysis of Bioactive Constituents and Their Anti‐Lung Cancer Mechanisms in Clinical Traditional Chinese Medicine Formulations},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71606}
}
Kostenlos starten →